In 1986, the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) was mandated to develop a brief neuropsychological assessment battery (CERAD-NAB) for AD, for uniform neuropsychological assessment, and information aggregation. Initially used across the National Institutes of Aging-funded Alzheimer’s Disease Research Centers, it has become widely adopted wherever information is desired on cognitive status and change therein, particularly in older populations.
Objective:
Our purpose is to provide information on the multiple uses of the CERAD-NAB since its inception, and possible further developments.
Methods:
Since searching on “CERAD neuropsychological assessment battery” or similar terms missed important information, “CERAD” alone was entered into PubMed and SCOPUS, and CERAD-NAB use identified from the resulting studies. Use was sorted into major categories, e.g., psychometric information, norms, dementia/differential dementia diagnosis, epidemiology, intervention evaluation, genetics, etc., also translations, country of use, and alternative data gathering approaches.
Results:
CERAD-NAB is available in ∼20 languages. In addition to its initial purpose assessing AD severity, CERAD-NAB can identify mild cognitive impairment, facilitate differential dementia diagnosis, determine cognitive effects of naturally occurring and experimental interventions (e.g., air pollution, selenium in soil, exercise), has helped to clarify cognition/brain physiology-neuroanatomy, and assess cognitive status in dementia-risk conditions. Surveys of primary and tertiary care patients, and of population-based samples in multiple countries have provided information on prevalent and incident dementia, and cross-sectional and longitudinal norms for ages 35–100 years.
Conclusion:
CERAD-NAB has fulfilled its original mandate, while its uses have expanded, keeping up with advances in the area of dementia.
FillenbaumGG, van BelleG, MorrisJC, MohsRC, MirraSS, DavisPC, TariotPN, SilvermanJM, ClarkCM, Welsh-BohmerKA, HeymanA (2008) CERAD (Consortium to Establish a Registry for Alzheimer’s Disease): The first 20 years. Alzheimers Dement4, 96–109.
2.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
3.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
4.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders:DSM-5™, 5th ed., American Psychiatric Publishing, Inc., Arlington,VA, US.
5.
LuckT, PabstA, RodriguezFS, SchroeterML, WitteV, HinzA, MehnertA, EngelC, LoefflerM, ThieryJ, VillringerA, Riedel-HellerSG (2018) Age-, sex-, and education-specific norms for an extended CERAD Neuropsychological Assessment Battery-results from the population-based LIFE-Adult-Study. Neuropsychology32, 461–475.
6.
SchmidNS, EhrenspergerMM, BerresM, BeckIR, MonschAU (2014) The extension of the German CERAD Neuropsychological Assessment Battery with tests assessing subcortical, executive and frontal functions improves accuracy in dementia diagnosis. Dement Geriatr Cogn Disord Extra4, 322–334.
TeunissenCE, VerberkIMW, ThijssenEH, VermuntL, HanssonO, ZetterbergH, van der FlierWM, MielkeMM, Del CampoM (2022) Blood-based biomarkers for Alzheimer’s disease: Towards clinical implementation. Lancet Neurol21, 66–77.
9.
LovestoneS, FrancisP, KloszewskaI, MecocciP, SimmonsA, SoininenH, SpengerC, TsolakiM, VellasB, WahlundLO, WardM, AddNeuroMed Consortium (2009) AddNeuroMed–the European collaboration for the discovery of novel biomarkers for Alzheimer’s disease. Ann N Y Acad Sci1180, 36–46.
10.
LangaKM, RyanLH, RJ, JonesRN, ManlyJJ, LevineDA, SonnegaA, FarronM, WeirDA (2020) The Health and Retirement Study harmonized cognitive assessment. Neuroepidemiology54, 64–74.
11.
KaplanEF, GoodglassH, WeintraubS (1978) The Boston Naming Test. Veterans Administration Medical Center, Boston, MA.
12.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
13.
RosenWG, MohsRC, DavisKL (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry141, 1356–1364.
14.
ChandlerMJ, LacritzLH, HynanLS, BarnardHD, AllenG, DeschnerM, WeinerMF, CullumCM (2005) A total score for the CERAD neuropsychological battery. Neurology65, 102–106.
15.
SeoEH, LeeDY, LeeJH, ChooIH, KimJW, KimSG, ParkSY, ShinJH, DoYJ, YoonJC, JhooJH, KimKW, WooJI (2010) Total scores of the CERAD neuropsychological assessment battery: Validation for mild cognitive impairment and dementia patients with diverse etiologies. Am J Geriatr Psychiatry18, 801–809.
16.
EhrenspergerMM, BerresM, TaylorKI, MonschAU (2010) Early detection of Alzheimer’s disease with a total score of the German CERAD. J Int Neuropsychol Soc16, 910–920.
17.
WolfsgruberS, JessenF, WieseB, SteinJ, BickelH, MöschE, WeyererS, WerleJ, PentzekM, FuchsA, KöhlerM, BachmannC, Riedel-HellerSG, SchererM, MaierW, WagnerM, for the AgeCoDe study group (2014) The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy. Am J Geriatr Psychiatry10, 1017–1028.
18.
PaajanenT, HänninenT, TunnardC, HallikainenM, MecocciP, SobowT, TsolakiM, VellasB, LovestoneS, SoininenH (2014) CERAD neuropsychological compound scores are accurate in detecting prodromal Alzheimer’s disease: A prospective AddNeuroMed study. J Alzheimers Dis39, 679–690.
19.
Aguirre-AcevedoDC, Jaimes-BarragánF, HenaoE, TiradoV, MuñozC, ReimanEM, TariotPN, LangbaumJB, LoperaF (2016) Diagnostic accuracy of CERAD total score in a Colombian cohort withmild cognitive impairment and Alzheimer’s disease affected by E280Amutation on presenilin-1 gene. Int Psychogeriatr28, 503–510.
20.
MorrisJC (1993) The clinical dementia rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
21.
BretonA, CaseyD, ArnaoutoglouNA (2019) Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta-analysis of diagnostic accuracy studies. Int J Geriatr Psychiatry34, 233–242.
22.
Welsh-BohmerKA, MohsRC (1997) Neuropsychological assessment of disease. Neurology49(Suppl 3), S11–S13.
23.
FillenbaumGG, HeymanA, HuberMS, GanguliM, UnverzagtFW (2001) Performance of elderly African American and White community residents on the CERAD neuropsychological battery. J Int Neuropsychol Soc7, 502–509.
24.
ZhangXue-yan, ZhouYu-jing, LiuKPY (2012) Inter-rater reliability and receiver operating characteristic of Chinese Consortium to Establish a Registry for Alzheimer’s Disease: Neuropsychological Assessment Battery. Chin J Rehabil Theory Pract18, 837–839.
MorrisJC, HeymanA, MohsRC, HughesJP, van BelleG, FillenbaumG, MellitsED, ClarkC, and the CERAD investigators (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology39, 1159–1165.
27.
FillenbaumGG, UnverzagtFW, GanguliM, Welsh-BohmerKA, HeymanA (2002) The CERAD Neuropsychological Battery: Performance of representative community and tertiary care samples of African American and European American elderly. In Minority and cross-cultural aspects of neuropsychological assessment, Ferraro FR, ed. Swets and Zeitlinger, Lisse, The Netherlands, pp. 45-62.
28.
GanguliM, RatcliffG, DeKoskyST (1997) Cognitive test scores in community-based older adults with and without dementia. Aging Ment Health1, 176–180.
29.
MorrisJC, EdlandS, ClarkC, GalaskoD, KossE, MohsR, van BelleG, FillenbaumG, HeymanA (1993) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): Part IV. Rates of cognitive change, a longitudinal assessment of probable Alzheimer’s disease. Neurology43, 457–465.
30.
RossettiHC, CullumCM, HynanLS, LacritzLH (2010) The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord24, 138–142.
31.
LiuKPY, KuoMCC, TangK-C, ChauAWS, HoIHT, KwokMPH, ChanWCW, ChoiRHK, LamNCW, ChuMML, Leung-Wing ChuL-W (2011) Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer’s Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders. Int Psychogeriatr23, 1575–1581.
32.
HänninenT, PulliainenV, SotaniemiM, HokkanenL, SaloJ, HietanenM, PirttiläT, PöyhönenM, JuvaK, RemesA, ErkinjunttiT (2010) [Early detection of cognitive changes in memory diseases: New cut-off scores for the Finnish version of CERAD neuropsychological battery]. [Muistisairauksien tiedonkäsittelymuutosten varhainen toteaminen uudistetulla CERAD-tehtäväsarjalla.] Duodecim; lääketieteellinen aikakauskirja, 126, 2013–2021.
33.
AebiC (2002) Validierung der neuropsychologischen Testbatterie CERAD-NP: Eine multi-center studie. PhD thesis, University of Basel, Switzerland. <edoc.unibas.ch>
34.
BerresM, MonschAU, BernasconiF, ThalmannB, StähelinHB (2000) Normal ranges of neuropsychological tests for the diagnosis of Alzheimer’s disease. Stud Health Technol Inform77, 195–199.
35.
KimSY, LeeHK (2018) Comparison of mild cognitive impairment (MCI) diagnostic validity in neuropsychological tests for dementia. Asia Life Sciences1, 301–310.
36.
Aguirre-AcevedoDC, GómezRD, MorenoS, Henao-ArboledaE, MottaM, MuñozC, AranaA, PinedaDA, LoperaF (2007) Validity and reliability of the CERAD-Col neuropsychological battery [Validez y fiabilidad de la batería neuropsicológica CERAD-Col]. Rev Neurol45, 655–660.
37.
DiehlJ, MonschAU, AebiC, WagenpfeilS, KrappS, GrimmerT, SeeleyW, FörstlH, KurzA (2005) Frontotemporal dementia, semantic dementia, and Alzheimer’s disease: The contribution of standard neuropsychological tests to differential diagnosis. J Geriatr Psych Neur18, 39–44.
38.
CollieA, Shafiq-AntonacciR, MaruffP, TylerP, CurrieJ (1999) Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust N Z J Psychiatry33, 568–575.
39.
WelshKA, ButtersN, MohsRC, BeeklyD, EdlandS, FillenbaumG, HeymanA (1994) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology44, 609–614.
40.
HanJY, SeoEH, YiD, SohnBK, ChoeYM, ByunMS, ChoiHJ, KimSG, ParkSY, KimJW, YounJC, JhooJH, LeeJH, KimKW, WooJI, LeeDY (2014) A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population. Int Psychogeriatr26, 1897–1904.
41.
WadleyVG, UnverzagtFW, McGuireLC, MoyCS, GoR, KisselaB, McClureLA, CroweM, HowardVJ, HowardG (2011) Incident cognitive impairment is elevated in the stroke belt: The REGARDS Study. Ann Neurol70, 229–236.
42.
GoodwillAM, CampbellS, HendersonVW, GorelikA, DennersteinL, McClungM, SzoekeC (2019) Robust norms for neuropsychological tests of verbal episodic memory in Australian women. Neuropsychology33, 581–595.
43.
KomulainenP, TuomilehtoJ, SavonenK, MännikköR, HassinenM, LakkaTA, HänninenT, KiviniemiV, JacobsDRJr, KivipeltoM, RauramaaR (2021) Exercise, diet, and cognition in a 4-year randomized controlled trial: Dose-Responses to Exercise Training (DR’s EXTRA). Am J Clin Nutr113, 1428–1439, and supplement.
44.
SaariT, HallikainenI, HänninenT, RätyH, KoivistoA (2018) Relationships between cognition and activities of daily living in Alzheimer’s disease during a 5-Year follow-up: ALSOVA study. J Alzheimers Dis64, 69–79.
LeeJH, LeeKU, LeeDY, KimKW, JhooJH, KimJH, LeeKH, KimSY, HanSH, WoJI (2002) Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease assessment packet (CERAD-K): Clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci57, P47–P53.
47.
StraussME, FritschT (2004) Factor structure of the CERAD neuropsychological battery. J Int Neuropsychol Soc10, 559–565.
48.
JonesSN, AyersCR (2006) Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample. Arch Clin Neuropsychol21, 359–365.
49.
GurujeO, UnverzargtFW, OsuntokunBO, HendrieHC, BaiyewuO, OgunniyiA, HaliKS (1995) The CERAD Neuropsychological TestBattery: Norms from a Yoruba-speaking Nigerian sample. W Afr JMed14, 29–33.
50.
UnverzagtFW, HallKS, TorkeAM, RedigerJD, MercadoN, GurejeO, OsuntokunBO, HendrieHC (1996) Effects of age, education, and gender on CERAD neuropsychological test performance in an African-American sample. Clin Neuropsychol10, 180–190.
51.
RöhrF, BucholtzN, ToepferS, NormanK, SpiraD, Steinhagen-ThiessenE, LillCM, BertramL, DemuthI, BuchmannN, DüzelS (2020) Relationship between Lipoprotein (a) and cognitive function –Results from the Berlin Aging Study II. Sci Rep10, 10636.
52.
MathewsM, AbnerE, Caban-HoltA, KryscioR, SchmittF (2013) CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatr25, 1115–1123.
53.
ZehnderAE, BläsiS, BerresM, SpiegelR, MonschAU (2007) Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?Am J Alzheimers Dis22, 416–426.
54.
CamargoCHF, JustusFF, RetzlaffG (2015) The effectiveness of reality orientation in the treatment of Alzheimer’s disease. Am J Alzheimers Dis30, 527–532.
55.
KryscioRJ, AbnerEL, SchmittFA, GoodmanPJ, MendiondoM, Caban-HoltA, DennisBC, MathewsM, KleinEA, CrowleyJJ, for the SELECT investigators (2013) A randomized controlled Alzheimer’s disease prevention trial’s evolution into an exposure trial: The PReADVISE trial. J Nutr Health Aging17, 72–75.
56.
SteinJ, LuppaM, LuckT, MaierW, WagnerM, DaerrM, van den BusscheH, ZimmermannT, KöhlerM, BickelH, MöschE, WeyererS, KaufelerT, PentzekM, WieseB, WollnyA, KönigH-H, Riedel-HellerSG (2012) The assessment of changes in cognitive functioning: Age, education, and gender-specific reliable change indices for older adult Germans tested on the CERAD-NP battery: Results of the study on ageing, cognition, and dementia in primary care patients (AgeCoDe). Am J Geriatr Psychiatry20, 84–97.
57.
EhrekeL, LuppaM, LuckT, WieseB, WeyererS, Eifflaender-GorferS, WeegD, OlbrichJ, van den BusscheH, BachmannC, EiseleM, MaierW, JessenF, WagnerM, FuchsA, PentzekM, AngermeyerMC, KönigHH, Riedel-HellerSG; AgeCoDe group (2009) Is the clock drawing test appropriate for screening for mild cognitive impairment? Results of the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord28, 365–372.
58.
IraniparastM, ShiY, WuY, ZengL, MaxwellCJ, KryscioRJ, St JohnPD, SantaCruzKS, TyasSL (2022) Predictors and rates of reversion to intact cognition vs progression to dementia. Neurology98, e1114–e1123.
59.
SnowdonDA (2003) Healthy aging and dementia: Findings from the Nun Study. Ann Intern Med139, 450–454.
60.
FisherNJ, RourkeBP, BieliauskasLA (1999) Neuropsychological subgroups of patients with Alzheimer’s disease: An examination of the first 10 years of CERAD data. J Clin Exp Neuropsychol21, 488–518.
61.
FillenbaumGG, WoodburyMA (1998) Typology of Alzheimer’s disease: Findings from CERAD data. Aging Ment Health2, 105–127.
62.
VogelJW, YoungAL, OxtobyNP, SmithR, OssenkoppeleR, StrandbergOT, La JoieR, AksmanLM, GrotheMJ, Iturria-MedinaY, the Alzheimer’s Disease Neuroimaging Initiative, PontecorvoMJ, DevousMD, RabinoviciGL, AlexanderDC, LyooCH, EvansAC, Oskar HanssonO (2021) Four distinct trajectories of tau deposition identified in Alzheimer’s disease. Nat Med27, 871–881.
63.
TunvirachaisakulC, SupasitthumrongT, TangwongchaiS, HemrunrojS, ChuchuenP, TawankanjanachotI, LikitchareonY, PhanthumchindaK, SriswasdiS, MaesM (2018) characteristics of mild cognitiveimpairment using the Thai version of the Consortium to Establish aRegistry for Alzheimer’s Disease Tests: A multivariate and machinelearning study. Dement Geriatr Cogn45, 38–48.
64.
GurevichP, StukeH, KastrupA, StukeH, HildebrandtH (2017) Neuropsychological testing and machine learning distinguish Alzheimer’s disease from other causes for cognitive impairment. Front Aging Neurosci9, 114.
65.
HappawanaKA, DiamondBJ (2019) The applicability of association rule learning (FP-Growth) in neuropsychological data analysis: Profiles and predictors for Alzheimer’s disease. PhD dissertation, Department of Psychology, William Paterson University, Wayne, NJ.
66.
ChenP, RatcliffG, BelleSH, CauleyJA, DeKoskyST, GanguliM (2001) Patterns of cognitive decline in presymptomatic Alzheimer disease: A prospective community study. Arch Gen Psychiatry58, 853–858.
67.
AndrejevaN, KnebelM, Dos SantosV, SchmidtJ, HeroldCJ, TudoranR, WetzelP, WendelsteinB, Meyer-KühlingI, NavratilSD, Gorenc-MahmutajL, RosenbaumG, PantelJ, SchröderJ (2016) Neurocognitive deficits and effects of cognitive reserve in mild cognitive impairment. Dement Geriatr Cogn41, 199–209.
68.
SchmidtkeK, HermeneitS (2008) High rate of conversion to Alzheimer’s disease in a cohort of amnestic MCI patients. Int Psychogeriatr20, 96–108.
69.
DiehlJ, KurzA (2002) Frontotemporal dementia: Patient characteristics, cognition, and behaviour. Int J Geriatr Psychiatry17, 914–918.
70.
HaanpääRM, SuhonenN-M, HartikainenP, KoivistoAM, MoilanenV, HerukkaS-K, HänninenT, RemesAM (2015) The CERAD neuropsychological battery in patients with frontotemporal lobar degeneration. Dement Geriatr Cogn Extra5, 147–154.
71.
CherrierMM, MendezMF, FerrymanKM, PachanaNA, MillerBL, CummingsJL (1997) Frontotemporal dementia versus vascular dementia: Differential features on mental status examination. J Am Geriatr Soc45, 579–583.
72.
KünigG, JägerM, StiefV, KalduneA, UrbaniokF, EndrassJ (2006) The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer’s disease. Int J Geriatr Psychiatry21, 911–916.
Arango-LasprillaJC, Iglesias-DoradoJ, MorenoS, LoperaF (2003) A neuropsychological study of Huntington’s disease in families in Antioquia, Colombia [Estudio neuropsicológico de la enfermedad de Huntington en familias de Antioquia, Colombia]. Rev Neurol37, 7–13.
75.
HarveyPD, LombardiJ, LeibmanM, WhiteL, ParrellaM, PowchikP, MohsRC, DavidsonM (1996) Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia. Int J Geriatr Psychiatry11, 621–627.
76.
KanchanatawanB, ThikaS, SirivichayakulS, CarvalhoAF, GeffardM, MaesM (2018) In schizophrenia, depression, anxiety, andphysiosomatic symptoms are strongly related to psychotic symptomsand excitation, impairments in episodic memory, and increasedproduction of neurotoxic tryptophan catabolites: A multivariate andmachine learning study. Neurotoxicity Res33, 641–655.
77.
CamargoCHF, BronziniA, TolentinoES, MedykC, Schultz-PereiraGL (2018) Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson’s disease? [A bateria neuropsicológica do CERAD pode ser usada para avaliação cognitiva em pacientes com doença de parkinson?]Arq Neuro-Psiquiat76, 145–149.
78.
KalbeE, RehbergSP, HeberI, KronenbuergerM, SchulzJB, StorchA, LinseK, SchneiderC, GräberS, Liepelt-ScarfoneI, BergD, DamsJ, Balzer-GeldsetzerM, HilkerR, OberschmidtC, WittK, SchmidtN, MollenhauerB, TrenkwalderC, SpottkeA, RoeskeS, WittchenH-U, RiedelO, DodelR (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: Evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry87, 1099–1105.
79.
FinkA, BuchmannN, TegelerC, Steinhagen-ThiessenE, DemuthI, DoblhammerG (2017) Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany. PLoS One12, e0187119.
80.
Guerrero-BerroaE, Ravona-SpringerR, SchmeidlerJ, SilvermanJM, SanoM, KoifmannK, PreissR, HoffmanH, HeymannA, Schnaider BeeriM (2014) Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes. Int J Geriatr Psychiatry29, 299–309.
81.
GoettelN, BurkhartCS, RossiA, CabellaBCT, BerresM, MonschAU, CzosnykaM, SteinerLA (2017) Associations between impaired cerebral blood flow autoregulation, cerebral oxygenation, and biomarkers of brain injury and postoperative cognitive dysfunction in elderly patients after major noncardiac surgery. Anesth Analg124, 934–942.
SilbertB, EveredL, ScottDA, McMahonS, ChoongP, AmesD, MaruffP, JamrozikK (2015) Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology122, 1224–1234.
85.
CardosoBR, ApolinárioD, da Silva BandeiraV, BusseAL, MagaldiRM, Jacob-FilhoW, CozzolinoSMF (2016) Effects of Brazil nutconsumption on selenium status and cognitive performance in olderadults with mild cognitive impairment: A randomized controlled pilottrial. Eur J Nutr5, 107–116.
86.
GaoS, JinY, HallKS, LiangC, UnverzagtFW, JiR, MurrellJR, CaoJ, ShenJ, MaF, MatesanJ, YingB, ChengY, BianJ, LiP, HendrieHC (2007) Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol165, 955–965.
87.
AltugH, FuksKB, HülsA, MayerA-K, ThamR, KrutmannJ, SchikowskiT (2020) Air pollution is associated with depressive symptoms in elderly women with cognitive impairment. Environ Int136, 105448.
88.
TschanzJT, NortonMC, ZandiPP, LyketsosCG (2013) The Cache County Study on Memory in Aging: Factors affecting risk of Alzheimer’s disease and its progression after onset. Int Rev Psychiatry5, 673–685.
89.
PetersO, HeuserI, FrölichL, RütherE, RienhoffO, KornhuberJ, WiltfangJ, MaierW (2016) Das Kompetenznetz Demenzen. Erfolge und Ausblicke [Dementia Competence Network. Results and outlook]Bundesgesundheitsbl59, 438–443.
90.
RodriguezFS, SchroeterML, ArélinK, WitteAV, BaberR, BurkhardtR, EngelC, LöfflerM, ThieryJ, VillringerA, LuckT, Riedel-HellerSG (2018) APOE e4-genotype and lifestyle interactionon cognitive performance: Results of the LIFE-adult-study. Health Psychol37, 194–205.
91.
Sepulveda-FallaD, GlatzelaM, LoperaF (2012) Profile of early-onset familial Alzheimer’s disease caused by presenilin-1 E80A mutation. J Alzheimers Dis32, 1–12.
92.
SupasitthumrongT, TunvirachaisakulC, AniwattanapongD, TangwongchaiS, ChuchuenP, TawankanjanachotI, SnabboonT, HemrungrojnS, CarvalhoAF, MaesM (2019) Peripheral blood biomarkers coupled with the apolipoprotein E4 genotype are strongly associated with semantic and episodic memory impairments in elderly subjects with amnestic mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis71, 797–811.
93.
UmlaufE, RappoldE, SchillerB, FuchsP, RainerM, WolfB, ZellnerM (2016) Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer’s disease. Oncotarget7, 39108–39117.
94.
AlmeidaOP, SchwabSG, LautenschlagerNT, MorarB, GreenopKR, FlickerL, WildenauerD (2008) KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J Cell Mol Med12, 1672–1676.
95.
FehselK, SchikowskiT, JännerM, HülsA, VoussoughiM, SchulteT, VierkötterA, TeichertT, HerderC, SugiriD, KrämerU, Christian LuckhausC (2016) Estrogen receptor beta polymorphisms and cognitive performance in women: Associations and modifications by genetic and environmental influences. J Neural Transm123, 1369–1379.
96.
Balzer-GeldsetzerM, Braga da CostaASF, KronenbürgerM, SchulzJB, RöskeS, SpottkeA, WüllnerU, KlockgetherT, StorchA, SchneiderC, RiedelO, WittchenH-W, SeifriedC, HilkerR, SchmidtN, WittK, DeuschlG, MollenhauerB, TrenkwalderC, Liepelt-ScarfoneI, Gräber-SultanS, BergD, GasserT, KalbeE, BoddenM, OertelWH, DodelR (2011) Parkinson’s disease and dementia: A longitudinal study (DEMPARK). Neuroepidemiology37, 168–176.
97.
RickenbacherM, ReinboldCS, HermsS, HoffmannP, CichonS, WueestAS, MonschAU, SteinerLA, GoettelN (2022) Genome-wide association study of postoperative cognitive dysfunction in older surgical patients. J Neurosurg Anesthesiol34, 248–250.
98.
ChoiM, YounH, KimD, LeeS, SuhS, SeongJ-K, JeongH-G, HanCE (2019) Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer’s dementia. PLoS One14, e0220739.
99.
LimHK, HongSC, JungWS, AhnKJ, WonWY, HahnC, KimIS, LeeCU (2013) Automated segmentation of hippocampal subfields in drug-naïve patients with Alzheimer disease. Am J Neuroradiol34, 747–751.
100.
SonJH, HanDH, MinKJ, KeeBS (2013) Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer’s disease. Neurosci Lett548, 15–20.
101.
KreuzerA, SauerbeckJ, ScheifeleM, StockbauerA, SchöneckerS, PrixC, WlasichE, LoosliSV, KazmierczakPM, UnterrainerM, CatakC, JanowitzD, PogarellO, PalleisC, PerneczkyR, AlbertNL, BartensteinP, DanekA, BuergerK, LevinJ, ZwergalA, RomingerA, BrendelM, BeyerL (2021) Detection gap of right-asymmetric neuronal degeneration by CERAD test battery in Alzheimer’s Disease. Front Aging Neurosci13, 611595.
102.
ObadiaY, RotilyM, Degrand-GuillaudA, GuelainJ, CeccaldiM, SeveroC, PoncetM, AlperovitchA (1997) The PREMAP study: Prevalence and risk factors of dementia and clinically diagnosed Alzheimer’s disease in Provence, France. Eur J Epidemiol13, 247–253.
103.
PrinceM, AcostaD, ChiuH, ScazufcaM, VargheseM, for the 10/66 Dementia Research (2003) Dementia diagnosis in developing countries: A cross-cultural validation study. Lancet361, 909–917.
104.
DemersP, RobillardA, LaflècheG, NashF, HeymanA, FillenbaumG (1994) Translation of clinical and neuropsychological instruments into French: The CERAD experience. Age Ageing23, 449–451.
105.
AlobaidyA, Al-SinawiH, Al-AsmiA, Al-AdawiS, Mohamed EssaM, El-OklM, JeyaseelanL, AlsawafiL, AlmawaliM, AlabriB, AlhamrashdiH (2016) CERAD Neuropsychological Battery-Arabic Version: Regression-based and stratified normative data and effects of demographic variables on cognitive performance in older Omanis. Cogn Behav Neurol30, 150–158.
LarsonEB, McCurrySM, GravesAB, BowenJD, RiceMM, McCormickWC, HommaA, ImaiY, WhiteL, MasakiK, PetrovitchH, RossW, YamadaM, MimoriY, SasakiH (1998) Standardization of the clinical diagnosis of the dementia syndrome and its subtypes in a cross-national study: The Ni-Hon-Sea experience. J Gerontol Med Sci53A, M313–M319.
108.
LeeDY, LeeJH, JuYS, LeeKU, KimKW, JhooJH, YoonJC, HaJ, WooJI (2002) The prevalence of dementia in older people in an urban population of Korea: The Seoul study. J Am Geriatr Soc50, 1233–1239.
109.
AniwattanapongD, TangwongchaiS, SupasitthumrongaT, HemrunrojS, TunvirachaisakulC, TawankanjanachotaI, ChuchuenaP, SnabboonT, CarvalhodAF, MaesaM (2019) Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer’s dementia and mild cognitive impairment: Clinical and biomarker correlates. Aging Ment Health23, 840–850.
110.
KavéG (2005) Standardization and norms for a Hebrew namingtest. Brain Lang92, 204–211.
111.
ChandraV, GanguliM, PandavR, JohnstonJ, BelleS, DeKoskyST (1998) Prevalence of Alzheimer’s disease and other dementias in rural India: The Indo-US study. Neurology51, 1000–1008.
112.
GanguliM, ChandraV, GilbyJE, RatcliffG, SharmaSD, PandavR, SeabergEC, BelleS (1996) Studies on cognition and dementia. Cognitive test performance in a community-based nondemented elderly sample in rural India: The Indo-U.S. Cross-national Dementia Epidemiology study. Int Psychogeriatr8, 507–524.
113.
MonschAU (1997) Neuropsychological assessment of dementia [Die neuropsychologische untersuchung bei demenzabklärungen]. Praxis86, 1340–1342.
114.
StähelinHB, MonschAU, SpiegelR (1997) Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Psychogeriatr9(Suppl 1), 13–130.
115.
ThalmannB, MonschAU, SchneitterM, BernasconiF, AebiC, Camachova-DavetZ, StaehelinHB (2000) The CERAD neuropsychological assessment battery (CERAD-NAB) - A minimal dataset as a common tool for German-speaking Europe. Neurobiol Aging1, 30. Conference Abstract.
116.
BerresM, ZehnderA, BläsiS, MonschAU (2008) Evaluation of diagnostic scores with adjustment for covariates. Stat Med27, 1777–1790.
117.
JoddrellP, AstellAJ (2016) Studies involving people with dementia and touchscreen technology: A literature review. JMIR Rehabil Assist Technol3, e10.
118.
RitchieK, AllardM, HuppertFA, NargeotC, PinekB, LedesertB (1993) Computerized cognitive examination of the elderly (ECO): The development of a neuropsychological examination for clinic and population use. Int J Geriatr Psychiatry8, 899–914.
119.
Addison-BrownKJ, LetterAJ, YaggiK, McclureLA, UnverzagtFW, HowardVJ, LichtmanJH, WadleyVG (2014) Age differences in the association of obstructive sleep apnea risk with cognition and quality of life. J Sleep Res23, 69–76.
120.
HowardVJ, CushmanM, PulleyL, GomezCR, GoRC, PrineasRJ, GrahamA, MoyCS, HowardG (2005) The REasons for Geographic And Racial Differences in Stroke (REGARDS) study: Objectives and design. Neuroepidemiology25, 135–143.
121.
MarceauxJC, ProsjeMA, McClureLA, KanaB, CroweM, KisselaB, ManlyJ, HowardG, TamJW, UnverzagtFW, WadleyVG (2019) Verbal fluency in a national sample: Telephone administration methods. Int J Geriatr Psychiatry34, 578–587.
122.
ChiYK, HanJW, JeongH, ParkJY, KimTH, LeeJJ, LeeSB, Joon Hyuk ParkJH, YoonJC, KimJL, RyuS-H, JhooJH, LeeDY, KimKW (2014) Development of a screening algorithm for Alzheimer’s disease using categorical verbal fluency. PLoS One9, e84111.
123.
KwonSJ, KimHS, HanJH, BaeJB, HanJW, KimKW (2021) Reliability and validity of Alzheimer’s disease screening with a semi-automated smartphone application using verbal fluency. Front Neurol12, 684902.
124.
TrenkleDL, ShankleWR, AzenSP (2007) Detecting cognitive impairment in primary care: Performance assessment of three screening instruments. J Alzheimers Dis11, 323–335.
125.
ShankleWR, RomneyAK, HaraJ, FortierD, DickMB, ChenJM, ChanT, SunX (2005) Methods to improve the detection of mild cognitiveimpairment. Proc Natl Acad Sci U S A102, 4919–4924.
126.
CokerLH, EspelandMA, RappSR, LegaultC, ResnickSM, HoganP, GaussoinS, DaileyM, ShumakerSA (2010) Postmenopausal hormone therapy and cognitive outcomes: The Women’s Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol118, 304–310.
127.
ShumakerSA, LegaultC, RappSR, ThalL, WallaceRB, OckeneJK, HendrixSL, JonesBN, 3rdAssafAR, JacksonRD, KotchenJM, Wassertheil-SmollerS, Wactawski-WendeJ; WHIMS Investigators (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: A randomized controlled trial. JAMA289, 2651–2662.
128.
GanguliM, SeabergE, BelleS, FischerL, KullerLH (1993) Cognitive impairment and the use of health services in an elderly rural population: The MoVIES Project. J Am Geriatr Soc41, 1065–1070.
129.
MacDonaldA, PritchardD (2000) A mathematical model of Alzheimer’s disease and the ApoE gene. ASTIN Bull30, 69–110.
130.
LangaKM, PlassmanBL, WallaceRB, HerzogAR, HeeringaSG, OfstedalMB, BurkeJR, FisherGG, FultzNH, HurdMD, PotterGG, RodgersWL, SteffensDC, DavidR., WeirDR, WillisRJ (2005) The Aging, Demographics, and Memory Study: Study design and methods. Neuroepidemiology25, 181–191.
131.
PlassmanBL, LangaKM, FisherGG, HeeringaSG, WeirDR, OfstedalMB, BurkeJR, HurdMD, PotterGG, RodgersWL, SteffensDC, WillisRJ, WallaceRB (2007) Prevalence of dementia in the United States: The Aging, Demographics, and Memory study. Neuroepidemiology29, 125–132.
132.
Welsh-BohmerKA, ØstbyeT, SandersL, PieperCF, HaydenKM, TschanzJT, NortonMCfor the Cache County Study Group (2009) Neuropsychological performance in advanced age: Influences of demographic factors and apolipoprotein E: Findings from the Cache County Memory Study. Clin Neuropsychol23, 77–99.
133.
GravesA, LarsonEB, EdlandSD, BowenJ, McCormickWC, McCurrySM, RiceMM, WenzlowA, UomotoJM (1996) Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State: The Kame Project. Am J Epidemiol144, 760–771.
134.
WhiteL, PetrovitchH, RossGW, MasakiKH, AbbottRD, TengEL, RodriguezBL, BlanchettePL, HavlikRJ, WergowskeG, ChiuD, FoleyDJ, MurdaughC, CurbJD (1996) Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA276, 955–960.
135.
GanguliM, RatcliffG, HuffFJ, BelleS, KancelMJ, FischerL, SeabergEC, KullerLH (1991) Effects of age, gender, and education on cognitive tests in a rural elderly community sample: Norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology10, 42–52.
136.
ChandraV, PandavR, DodgeHH, JohnstonJM, BelleSH, DeKoskyST, GanguliM (2001) Incidence of Alzheimer’s disease in a rural community in India: The Indo-US study. Neurology57, 985–989.
137.
HendrieHC, OsuntokunBO, HallKS, OgunniyiAO, HuiSL, UnverzagtFW, GurujeO, RodenbergCA, BaiyewuO, MusickBS (1995) Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry152, 1485–1492.
138.
HendrieHC, OgunniyiA, HallKS, BaiyewuO, UnverzagtFW, GurejeO, GaoS, EvansRM, OgunseyindeAO, AdeyinkaAO, MusickB, HuiSL (2001) Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA285, 739–747.
139.
BieniasJL, BeckettLA, BennettDA, WilsonRS, EvansDA (2003) Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis5, 349–355.
140.
FillenbaumGG, HeymanA, HuberMS, WoodburyMA, LeissJ, SchmaderKE, BohannonA, Trapp-MoenB (1998) The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol51, 587–595.
141.
TaylorHAJr. (2005) The Jackson Heart Study: An overview. Ethn Dis15(4 Suppl 6), S61–3. (Entire issue).
142.
The ARIC investigators (1989) The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol129, 687–702.
143.
GottesmanRF, AlbertMS, AlonsoA, CokerLH, CoreshJ, DavisSM, DealJA, McKhannGM, MosleyTH, SharrettAR, SchneiderALC, WindhamBG, WruckLM, KnopmanDS (2017) associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol74, 1246–1254.
144.
LevineDA, GrossAL, BriceñoEM, TiltonN, GiordaniBJ, SussmanJB, HaywardRA, BurkeJF, HingtgenS, ElkindMSV, ManlyJJ, GottesmanRF, GaskinDJ, SidneyS, SaccoRL, TomSE, WrightCB, YaffeK, GaleckiAT (2021) Sex differences in cognitive decline among us adults. JAMA Netw Open4, e210169.
145.
BrodyDJ, KramarowEA, TaylorCA, McGuireLC (2019) Cognitive performance in adults aged 60 and over: National Health and Nutrition Examination Survey, 2011–2014. National Health Statistics Reports; no. 126. National Center for Health Statistics, Hyattsville, MD.
146.
BennettDA, BuchmanAS, BoylePA, BarnesLL, WilsonRS, SchneiderJA (2018) Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis64, S161–S189.
147.
BennettDA, SchneiderJA, ArvanitakisZ, WilsonRS (2012) Overview and findings from the Religious Orders Study. Curr Alzheimer Res9, 628–645.
148.
BennettDA, SchneiderJA, BuchmanAS, BarnesLL, BoylePA, WilsonRS (2012) Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res9, 646–663.
149.
BarnesLL, RajC, ShahRC, AggarwalNT, BennettDA, SchneiderJ (2012) The Minority Aging Research Study: Ongoing efforts to obtainbrain donation in African Americans without dementia. CurrAlzheimer Res9, 734–745.
150.
GrayWK, PaddickS-M, KisoliA, DotchinCL, LongdonAR, ChaoteP, SamuelM, JusabaniAM, WalkerR (2014) Development and validation of the Identification and Intervention for Dementia in Elderly Africans (IDEA) study dementia screening instrument. J Geriatr Psychiatry Neurol27, 110–118.
151.
GrayWK, PaddickS-M, OgunniyiA, OlakehindeO, DotchinC, KissimaJ, UrasaS, KisoliA, RogathiJ, MushiD, AdebiyiA, HauleI, RobinsonL, WalkerR (2021) Population normative data for three cognitive screening tools for older adults in sub-Saharan Africa. Dement Neuropsychol15, 339–349.
152.
PaddickS-M, YosephM, GrayWK, AndreaD, BarberR, ColganA, DotchinC, UrasaS, KissimaJ, HauleI, KisoliA, RogathiJ, SaficS, MushiD, RobinsonL, WalkerRW (2021) Effectiveness of app-based cognitive screening for dementia by lay health workers in low resource settings. A validation and feasibility study in rural Tanzania. J Geriatr Psychiatry Neurol34, 613–621.
153.
LiuCK, LaiCL, TaiCT, LinR-T, YenYY, HowngSL (1998) Incidence and subtypes of dementia in southern Taiwan. Impact of socio-demographic factors. Neurology50, 572–1579.
154.
LinR-T, LaiC-L, TaiC-T, LiuC-K, YenY-Y, HowngS-L (1998) Prevalence and subtypes of dementia in southern Taiwan: Impact of age, sex, education, and urbanization. J Neurol Sci160, 67–75.
155.
PerquinM, SchullerA-M, VaillantM, DiederichN, BisdorffA, LenersJ-C, D’IncauM, Jean-LudewigL, HoffmannD, UlbrichtD, ThomaS, DondelingerR, HeuschlingP, CouffignalS, DartiguesJ-F, LairM-L (2012) The epidemiology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) in community-living seniors: Protocol of the MemoVie cohort study, Luxembourg. BMC Public Health12, 519.
156.
ParkJH, LimS, LimJY, KimK-I, HanMK, YoonIY, KimJM, ChangY-S, ChangCB, ChinHJ, ChoiEA, LeeSB, ParkYJ, PaikN-J, KimTK, JangHC, KimKW (2007) An overview of the Korean Longitudinal Study on Health and Aging. Psychiatry Investig4, 84–95.
157.
LeeSB, KimKW, YounJC, ParkJH, LeeJJ, KimM-H, ChoiEA, JhooJH, ChooIH, LeeDY, WooJI (2009) Prevalence of mild cognitive impairment and its subtypes are influenced by the application of diagnostic criteria: Results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Dement Geriatr Cogn28, 23–29.
158.
KimKW, ParkJH, KimMH, KimMD, KimBJ, KimSK, KimJL, MoonSW, BaeJN, WooJI, RyuSH, YoonJC, LeeNJ, LeeDY, LeeDW, LeeSB, LeeJJ, LeeJY, LeeCU, ChangSM, JhooJH, ChoMJ (2011) A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis23, 281–291.
159.
HanJW, SoY, KimTH, LeeDY, RyuS-H, KimSY, KimSG, KimS-K, YounJC, JhooJH, KimJL, LeeSB, LeeJJ, Kyung Phil KwakKP, MoonSW, KimBJ, BaeJN, WooJI, JoonHJ, ParkH, KimYJ, KimKW (2017) Prevalence rates of dementia and mild cognitive impairment are affected by the diagnostic parameter changes for neurocognitive disorders in the DSM-5 in a Korean population. Dement Geriatr Cogn Disord43, 193–203.
HanJW, KimTH, KwakKP, KimK, KimBJ, KimSG, KimJL, KimTH, MoonSW, ParkJY, ParkJH, ByunS, SuhSW, SeoJY, SoY, RyuSH, YounJC, LeeKH, LeeDY, LeeDW, LeeSB, LeeJJ, LeeJR, JeongH, JeongHG, JhooJH, HanK, HongJW, KimKW (2018) Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia. Psychiatry Investig15, 767–774.
162.
ByunMS, YiD, LeeJH, ChoeYM, SohnBK, LeeJY, ChoiHJ, BaekH, KimYK, LeeY-S, SohnC-H, Mook-JungI, ChoiM, Yu Jin LeeYJ, LeeDW, RyuS-H, KimSG, KimJW, WooJI, LeeDY, KBASE Research Group (2017) Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer’s Disease: Methodology and baseline sample characteristics. Psychiatry Investig14, 851–863.
163.
BaeJB, HanJW, KwakKP, KimBJ, KimSG, KimJL, KimTH, RyuS-H, MoonSW, ParkJH, YounJC, LeeDY, LeeDW, LeeSB, LeeJJ, JhooJH, KimKW (2019) Is dementia more fatal than previously estimated? A population-based prospective cohort study. Aging Dis10, 1–11.
164.
KangS-G, NaK-S, KangJM, YeonBK, LeeJ-Y, ChoS-J (2017) Dementia care by healthy elderly caregivers is associated with improvement of patients’ memory and the caregivers’ quality of life: A before and after study. Psychiatry Investig14, 458–462.
165.
PulliainenV, HänninenT, HokkanenL, TervoS, VanhanenM, PirttiläT, SoininenH (2007) Muistihäiriöiden seulonta - suomalaiset normit CERAD-tehtäväsarjalle [Screening for memory disorders - Finnish norms for the CERAD task series]. Lääkärilehti62, 1235–1241.
166.
KarraschM, LaineM (2003) Age, education and test performance on the Finnish CERAD. Acta Neurol Scand108, 97–101.
167.
KarraschM, SinerväE, GrönholmP, RinneJ, LaineM (2005) CERAD test performances in amnestic mild cognitive impairment and Alzheimer’s disease. Acta Neurol Scand111, 172–179.
168.
KarraschM, LaatuS, MartikainenK, MarttilaR (2013) CERAD test performance and cognitive impairment in Parkinson’s disease. Acta Neurol Scand128, 409–413.
169.
KarraschM, LaatuS, EllfolkU, MarttilaR, MartikainenK (2015) Education-corrected CERAD identifies MCI and dementia in Parkinson’s disease. Acta Neurol Scand131, 219–224.
BarberaM, KulmalaJ, LiskoI, PietiläE, RosenbergA, HallikainenI, HallikainenM, LaatikainenT, LehtisaloJ, NeuvonenE, RusanenM, SoininenH, TuomilehtoJ, NganduT, SolomonA, KivipeltoM (2020) Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: The CAIDE85+ study protocol. BMC Geriatr20, 238.
172.
UusvaaraJ, PitkalaKH, KautiainenH, TilvisRS, StrandbergTE (2013) Detailed cognitive function and use of drugs with anticholinergic properties in older people: A community-based cross-sectional study. Drugs Aging30, 177–178.
173.
Morales-MuñozI, KoskinenS, PartonenT (2017) Differences in clinical and cognitive variables in seasonal affective disorder compared to depressive-related disorders: Evidence from a population-based study in Finland. Eur Psychiatry44, 9–16.
174.
LehtisaloJ, LindströmJ, NganduT, KivipeltoM, AhtiluotoS, Ilanne-ParikkaP, Keinänen-KiukaanniemiS, ErikssonJG, UusitupaM, TuomilehtoJ, LuchsingerJA, for the Finnish Diabetes Prevention Study (DPS) (2016) Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study. Diabetes/Metab Res Reviews32, 102–110.
175.
LehtisaloJ, LindströmJ, NganduT, KivipeltoM, AhtiluotoS, Ilanne-ParikkaP, Keinänen-KiukaanniemiS, ErikssonJG, UusitupaM, TuomilehtoJ, LuchsingerJ (2016) Association of long-term dietary fat intake, exercise, and weight with later cognitive function in the Finnish Diabetes Prevention Study. J Nutr Health Aging20, 146–154.
176.
VirtaJR, LaatuS, ParkkolaR, OikonenV, RinneJO, RuutiainenJ (2011) Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment. Mult Scler17, 931–938.
177.
Torniainen-HolmM, SuvisaariJ, LindgrenM, HärkänenT, DickersonF, YolkenRH (2019) The lack of association between herpes simplex virus 1 or toxoplasma gondii infection and cognitive decline in the general population: An 11-year follow-up study. Brain Behav Immun76, 159–164.
178.
HeinonenK, ErikssonJG, LahtiJ, KajantieE, PesonenAK, TuovinenS, OsmondC, RaikkonenK (2015) Late preterm birth and neurocognitive performance in late adulthood: A birth cohort study. Pediatrics135, e818–825.
179.
MännikköR, KomulainenP, SchwabU, HeikkiläHM, SavonenK, HassinenM, HänninenT, KivipeltoM, RauramaaR (2015) The Nordic diet and cognition –The DR’s EXTRA study. Brit J Nutr114, 231–239.
180.
KivipeltoM, MangialascheF, SnyderHM, AllegriR, AndrieuS, AraiH, BakerL, BellevilleS, BrodatyH, BruckiSM, World-Wide FINGERS Network (2020) A global approach to risk reduction and prevention of dementia. Alzheimers Dement16, 1078–1094.
181.
KivipeltoM, SolomonA, AhtiluotoS, NganduT, LehtisaloJ, AntikainenR, BäckmanL, HänninenT, JulaA, LaatikainenT, LindströmJ, MangialascheF, NissinenA, PaajanenT, PajalaS, PeltonenM, RauramaaR, Stigsdotter-NeelyA, StrandbergT, TuomilehtoJ, SoininenH (2013) The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress. Alzheimers Dement9, 657–665.
182.
NganduT, LehtisaloJ, LevalahtiE, LaatikainenT, LindstromJ, PeltonenM, SolomonA, AhtiluotoS, AntikainenR, HänninenT, JulaA, MangialascheF, PaajanenT, PajalaS, RauramaaR, StrandbergT, TuomilehtoJ, SoininenH, KivipeltoM (2014) Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-A randomized controlled lifestyle trial. Int J Environ Res Public Health11, 9345–9360.
183.
RosenbergA, NganduT, RusanenM, AntikainenR, BäckmanL, HavulinnaS, HänninenT, LaatikainenT, LehtisaloJ, LevälahtiE, LindströmJ, PaajanenT, PeltonenM, SoininenH, Stigsdotter-NeelyA, StrandbergT, TuomilehtoJ, SolomonA, KivipeltoM (2018) Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial. Alzheimers Dement14, 63–70.
184.
JessenF, WieseB, BickelH, Eiffländer-GorferS, FuchsA, KaduszkiewiczH, KöhlerM, LuckT, MöschE, PentzekM, Riedel-HellerSG, WagnerM, WeyererS, MaierW, van den BusscheH, for the AgeCoDe Study Group (2011) Prediction of dementia in primary care patients. PLoS One6, e16852.
185.
LuckT, Riedel-HellerSG, WieseB, SteinJ, WeyererS, WerleJ, KaduszkiewiczH, WagnerM, MöschE, ZimmermannT, MaierW, BickelH, van den BusscheH, JessenF, FuchsA, PentzekM (2009) CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German study on ageing, cognition and dementia in primary care patients (AgeCoDe) [CERAD-NP-Testbatterie: Alters-, geschlechts- und bildungsspezifische Normen ausgewählter Subtests. Ergebnisse der German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)]. Z Gerontol Geriatrie42, 372–384.
186.
LoefflerM, EngelC, AhnertP, AlfermannD, ArelinK, BaberR, BeutnerF, BinderH, BrählerE, BurkhardtR, CeglarekU, EnzenbachC, FuchsM, GlaesmerH, GirlichF, HagendorffA, HäntzschM, HegerlU, HengerS, HenschT, HinzA, HolzendorfV, HusserD, KerstingA, KielA, KirstenT, KratzschJ, KrohnK, LuckT, MelzerS, NettoJ, NüchterM, RaschpichlerM, RauscherFG, Riedel-HellerSG, SanderC, ScholzM, SchönknechtP, SchroeterML, SimonJC, SpeerR, StäkerJ, SteinR, Stöbel-RichterY, StumvollM, TarnokA, TerenA, TeupserD, ThenFS, TönjesA, TreudlerR, VillringerA, WeissgerberA, WiedemannP, ZachariaeS, WirknerK, ThieryJ (2015) The LIFE-Adult-Study: Objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health15, 691.
187.
RodriguezFS, SchroeterML, WitteAV, EngelC, LöfflerM, ThieryJ, VillringerA, LuckT, Riedel-HellerSG (2017) Could high mental demands at work offset the adverse association between social isolation and cognitive functioning? Results of the population-based LIFE-Adult-Study. Am J Geriatr Psychiat25, 1258–1269.
188.
BertramL, BöckenhoffA, DemuthI, DüzelS, EckardtR, LiS-C, LindenbergerU, PawelecG, SiedlerT, WagnerGG, Steinhagen-ThiessenE (2014) Cohort profile: The Berlin Aging Study II (BASE-II). Int J Epidemiol43, 703–712.
189.
DemuthI, BanszerusVL, DreweliesJ, DüzelS, SeelandU, SpiraD, TseE, BraunJ, Steinhagen-ThiessenE, BertramL, ThielA, LindenbergerU, Regitz-ZagrosekV, GerstorfD (2021) Cohort profile follow-up of a Berlin Aging Study II (BASE-II) subsample as part of the GendAge study. BMJ Open11, e04557.
190.
HülsA, VierkötterA, SugiriD, MichaelJ., AbramsonMJ, RanftU, KrämerU, SchikowskiT (2018) The role of air pollution and lung function in cognitive impairment. Eur Respir J51, 1701963.
191.
RanftU, SchikowskiT, SugiriD, KrutmannJ, KrämerU (2009) Long-term exposure to traffic-related particulate matter impairs cognitive function in the elderly. Environ Res109, 1004–1011.
192.
ZhaoQ, WigmannC, ArealAT, AltugH, SchikowskiT (2021) Effect of non-optimum ambient temperature on cognitive function of elderly women in Germany. Environ Pollut285, 117474.
193.
FuksKB, WigmannC, AltugH, SchikowskiT (2019) Road traffic noise at the residence, annoyance, and cognitive function in elderly women. Int J Environ Res Public Health16, 1790.
194.
RöhrS, ZülkeA, LuppaM, BrettschneiderC, WeißenbornM, KühneF, ZöllingerI, SamosFZ, BauerA, DöhringJ, Krebs-HeinK, OeyA, CzockD, FreseT, GensichenJ, HaefeliWE, HoffmannW, KaduszkiewiczH, KönigHH, ThyrianJR, WieseB, Riedel-HellerSG (2021) Recruitment and baseline characteristics of participants in the AgeWell.de study—a pragmatic cluster-randomized controlled lifestyle trial against cognitive decline. Int J Environ Res Public Health18, 408.
195.
BenkeT, DelazerM, SaninG, SchmidtH, SeilerS, RansmayrG, Dal-BiancoP, UranüsM, MarksteinerJ, LeblhuberF, KapellerP, BancherC, SchmidtR (2015) Cognition, gender, and functional abilities in Alzheimer’s disease: Howare they related?In Handbook of Depression in Alzheimer’s Disease. Smith GS, ed. pp. 129-134. Also in: (2015) Advances in Alzheimer’s Disease4, 129–134.
196.
DefrancescoM, MarksteinerJ, KemmlerG, Dal-BiancoP, RansmayrG, BenkeT, MosbacherJ, HöllerY, SchmidtR (2020) Specific neuropsychiatric symptoms are associated with faster progression in Alzheimer’s disease: Results of the Prospective Dementia Registry (PRODEM-Austria). J Alzheimers Dis73, 125–133.
197.
LuccaU, TettamantiM, TiraboschiP, LogroscinoG, LandiC, SaccoL, GarrìM, AmmessoS, BiottiA, GargantiniE, PiedicorciaA, MandelliS, RivaE, GalbusseraAA, RecchiaA (2015) Prevalence ofdementia in the oldest old: The Monzino 80-plus population-basedstudy. Alzheimers Dement11, 258–270.
198.
LuccaU, TettamantiM, LogroscinoG, TiraboschiP, LandiC, SaccoL, GarrìM, AmmessoS, BertinottiC, BiottiA, GargantiniE, PiedicorciaA, NobiliA, PasinaL, FranchiC, DjadeCD, RivaE, RecchiaA (2020) Incidence of dementia in the oldest-old and itsrelationship with age: The Monzino 80-plus population-based study. Alzheimers Dement16, 472–481.
199.
LuccaU, TettamantiM, MosconiP, ApoloneG, GandiniF, NobiliA, TalloneMV, DetomaP, GiacominA, ClericoM, TempiaP, GualaA, FasoloG, RivaE (2008) Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: The “Health and Anemia” Study. PLoS One3, e1920.
200.
KanchanatawanB, SriswasdiS, ThikaS, SirivichayakulS, CarvalhoAF, GeffardM, KuberaM, MaesM (2018) Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: Results of supervised machine learning. Metab Brain Dis33, 1053–1067.
201.
TangwongchaiS, SupasitthumrongT, HemrunrojS, TunvirachaisakulC, ChuchuenP, HoungngamN, SnabboonT, TawankanjanachotI, LikitchareonY, PhanthumchindadK, MaesM (2018) In Thai nationals, the ApoE4 allele affects multiple domains of neuropsychological, biobehavioral, and social functioning thereby contributing to Alzheimer’s disorder, while the ApoE3 allele protects against neuropsychiatric symptoms and psychosocial deficits. Mol Neurobiol55, 6449–6462.
202.
TepmongkolS, HemrungrojnS, DupontP, TunvirachaisakulC, AniwattanapongD, LikitjareonY, SupasitthumrongT, TawankanjanachotI, SiritranonN, ChuchuenP, NatsawangB, TangwongchaiS (2019) Early prediction of donepezil cognitive response in Alzheimer’s disease by brain perfusion single photon emission tomography. Brain Imaging Behav13, 1665–1673.
PaajanenT, HänninenT, TunnardC, MecocciP, SobowT, TsolakiM, VellasB, LovestoneS, SoininenH, Addneuromed Consortium (2010) CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: The AddNeuroMed study. J Alzheimers Dis22, 1089–1097.
205.
MarsegliaA, XuW, FratiglioniL, FabbriC, BerendsenAAM, Bialecka-DebekA, JenningsA, GillingsR, MeunierN, CaumonE, Fairweather-TaitS, PietruszkaB, De GrootLCPGM, SantoroA, FranceschiC (2018) Effect of the NU-AGE diet on cognitive functioning in older adults: A randomized controlled trial. Front Physiol9, 349.
206.
SoininenH, SolomonA, VisserPJ, HendrixSB, BlennowK, KivipeltoM, HartmannTLipiDiDiet clinical study group (2021) 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer’s disease. Alzheimers Dement17, 29–40.
207.
GuerchetM, MbelessoP, Ndamba-BandzouziB, PilleronS, DesormaisI, LacroixP, AboyansV, JésusP, DesportJ-C, TchallaAE, MarinB, LambertJ-C, ClémentJ-P, DartiguesJ-F, PreuxP-M (2014) Epidemiology of dementia in Central Africa (EPIDEMCA): Protocol fora multicentre population-based study in rural and urban areas of theCentral African Republic and the Republic of Congo. SpringerPlus3, 1–12.
208.
SaldanhaD, ManiMR, SrivastavaK, GoyalS, BhattacharyaD (2010) An epidemiological study of dementia under the aegis of mental health program, Maharashtra, Pune chapter. Indian J Psychiatry52, 131–139.
209.
TractenbergRE, FillenbaumGG, AisenPS, LiebkeDE, YumotoF, KuchibhatlaMN (2010) What the CERAD battery can tell us about executive function as a higher order cognitive faculty. Current Gerontol Geriatr Res2010, 510614.
210.
WeintraubS, CarrilloMC, FariasST, GoldbergTE, HendrixJA, JaegerJ, KnopmanDS, LangbaumJB, ParkDC, RopackiMT, SikkesSAM, Welsh-BohmerKA, BainLJ, BrashearR, BudurK, GrafA, MartenyiF, StorckMS, RandolphC (2018) Measuring cognition and function in the preclinical stage of Alzheimer’s disease. Alzheimers Dement (NY)4, 64–75.
211.
WeintraubS, BesserL, DodgeHH, TeylanM, FerrisS, GoldsteinFC, GiordaniB, KramerJ, LoewensteinD, MarsonD, MungasD, SalmonD, Welsh-BohmerK, ZhouXH, ShirkSD, AtriA, KukullWA, PhelpsC, MorrisJC (2018) Version 3 of the Alzheimer disease centers’ neuropsychological test battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord32, 10–17.
212.
HarbiZ, HicksY, SetchiaR (2016) Clock Drawing Test digit recognition using static and dynamic features. Procedia Computer Sci96, 1221–1230.
